Τόμος 27 (2009) – Τεύχος 1 – Άρθρο 19 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 27 (2009) – Issue 1– Article 19 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Στέφανος Μπονόβας^1,2, Νικόλαος Μ. Σιταράς¹

¹Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Πανεπιστήμιο Αθήνας, Αθήνα, Ελλάς
²Τμήμα Επιδημιολογικής Επιτήρησης και Παρέμβασης, Κέντρο Ελέγχου και Πρόληψης Νοσημάτων, Υπουργείο Υγείας και Κοινωνικής Αλληλεγγύης, Αθήνα, Ελλάς

Stefanos Bonovas^1,2, Nikolaos M. Sitaras¹

¹Department of Pharmacology, School of Medicine, University of Athens, M. Asias 75, 11527 Athens, Hellas
²Department of Epidemiological Surveillance and Intervention, Center for Diseases Control and Prevention, Ministry of Health and Social Solidarity, Hellas

2. Petitti D.: Meta-analysis, decision analysis and cost-effectiveness analysis. New York, NY: Oxford University Press; 1994

3. Dickersin K., Berlin J.A.: Meta-analysis: State-of-the-science. Epidemiol. Rev. 14: 155-176 (1992)

4. L’Abbe K.A., Detsky A.S., O’Rourke K.: Meta-analysis in clinical research. Ann. Intern. Med. 107: 224-233 (1987)

5. Olkin I.: Meta-analysis: reconciling the results of independent studies. Stat. Med. 14: 457-472 (1995)

6. Mantel N., Haenszel W.: Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22: 719-748 (1959)

7. DerSimonian R., Laird N.: Meta-analysis in clinical trials. Control Clin. Trials 7: 177-188 (1986)

8. Thompson S.G., Higgins J.P.: How should meta-regression analyses be undertaken and interpreted? Stat. Med. 21: 1559-1573 (2002)

9. Begg C.B., Mazumdar M.: Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101 (1994)

10. Egger M., Davey Smith G., Schneider M., Minder C.: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634 (1997)

11. Cochran W.G.: The combination of estimates from different experiments. Biometrics 8: 101-129 (1954)

12. Higgins J.P., Thompson S.G.: Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558 (2002)

13. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G.: Measuring inconsistency in meta-analyses. BMJ 327: 557-560 (2003)

14. Sporn M.: Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 36: 2699-2702 (1976)

15. Bonovas S., Tsantes A., Drosos T., Sitaras N.M.: Cancer chemoprevention: a summary of the current evidence. Anticancer Res. 28: 1857-1866 (2008)

16. Bonovas S., Filioussi K., Tsavaris N., Sitaras N.M.: Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J. Clin. Oncol. 24: 4808-4817 (2006)

17. Bonovas S., Filioussi K., Flordellis C., Sitaras N.M.: Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million subjects. J. Clin. Oncol. 25: 3462-3468 (2007)

18. Bonovas S., Filioussi K., Tsavaris N., Sitaras N.M.: Use of Statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. J. Clin. Oncol. 23: 8606-8612 (2005)

19. Bonovas S., Filioussi K., Tsavaris N., Sitaras N.M.: A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes – Reply. J. Clin. Oncol. 24: 2127-2128 (2006)

20. Bonovas S., Filioussi K., Tsavaris N., Sitaras N.M.: Lipophilic statins merit additional study for breast cancer chemoprevention – Reply. J. Clin. Oncol. 24: 2129 (2006)

21. Bonovas S., Filioussi K., Tsavaris N., Sitaras N.M.: Statins and breast cancer prevention: time for randomized controlled trials – Reply. J. Clin. Oncol. 24: 2130-2131 (2006)

22. Bonovas S., Filioussi K., Sitaras N.M.: Statin use and the risk of prostate cancer: a meta-analysis of 6 randomized clinical trials and 13 observational studies. Int. J. Cancer 123: 899-904 (2008)

23. Bonovas S., Filioussi K., Tsantes A., Sitaras N.M.: Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies. Br. J. Clin. Pharmacol. 64: 255-262 (2007)

24. Bonovas S., Filioussi K., Sitaras N.M.: Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies. Am. J. Gastroenterol. 103: 2646-26451 (2008)

25. Bonovas S., Sitaras N.M.: Statins and pancreatic cancer. Are all statins the same? – Response. Am. J. Gastroenterol. 104: 525 (2009)

26. Bonovas S., Sitaras N.M.: Does pravastatin promote cancer in elderly patients? A meta-analysis. CMAJ 176: 649-654 (2007)